Table 5.
Clinical data from tissue samples used in miR-150-5p second validation.
| Primary Tumor Tissue | Metastatic Lymph Node Tissue | Normal Prostate Tissue | ||||
|---|---|---|---|---|---|---|
| Total of samples | n = 15 | n = 5 | n = 20 | |||
| Age | ||||||
| Mean | 75.46 | 70.2 | 25.75 | |||
| Range | 51–90 | 62–78 | 22–30 | |||
| PSA (ng/mL) | ||||||
| Mean | 33.2 | - | - | |||
| Range | 0.7–106 | - | - | |||
| Gleason Score * | n | % | Gleason Score | n | % | |
| 3 + 4 | 4 | 26.67 | 3 + 4 | - | - | |
| 4 + 3 | 3 | 20 | 4 + 3 | - | - | |
| 4 + 4 | - | - | 4 + 4 | 1 | 20 | |
| 4 + 5 | 3 | 20 | 4 + 5 | 2 | 40 | |
| 5 + 4 | 3 | 20 | 5 + 4 | 2 | 40 | |
| 5 + 5 | 1 | 6.67 | 5 + 5 | - | - | |
| Stage ** | n | % | Number of Positive LNs | |||
| IIB | 2 | 13.33 | 2 | 1 | 20 | |
| IIIB | 2 | 13.33 | 4 | 1 | 20 | |
| IIC | 1 | 6.67 | 6 | 2 | 40 | |
| IIIC | 4 | 26.67 | 7 | 1 | 20 | |
| IV | 3 | 20 | ||||
* No Gleason score was reported for one sample of primary tumor. ** No tumoral stage was reported for two samples of primary tumor.